Chang Stephen Koon Bong
Transaction: 01/22/2026
OTHER
Change
0
Price
Not reported
Filing
02/02/2026
Type
OTHER
PIMCO High Income Fund
PHK • Asset Management - Income
$4.50
— 0.00 (0.00%)
Current price
EarningsLatest report: Dec 31, 2025
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$788.26M
Growth
-3.6%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 95.1%Positive free cash flow · 0.41Consistent free cash flow · 4/5Reasonable earnings multiple · 7.74Manageable debt level · 0.1
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Mar 4, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.50
Change0.00%
Shares Out175.17M
Market Cap$788.26M
Enterprise Value$1.15B
52W Range4.41 - 5.04
Beta0.58
P/E4.15
P/S4.70
P/B0.93
P/FCF4.85
EV/Sales6.88
Price$4.50
Change0.00%
Shares Out175.17M
Market Cap$788.26M
Enterprise Value$1.15B
52W Range4.41 - 5.04
Beta0.58
P/E4.15
P/S4.70
P/B0.93
P/FCF4.85
EV/Sales6.88
EV/EBITDA12.98
EV/FCF7.10
Earnings Yield24.10%
FCF Yield20.64%
Dividend Yield22.61%
Gross Margin95.33%
Oper. Margin95.15%
Profit Margin95.15%
Debt/Eq0.10
Current Ratio1.37
Quick Ratio1.37
Revenue 5Y-3.60%
FCF 5Y-9.91%
Volume869.86K
Avg Volume675.12K
Investment DNA
How strong this company looks for long-term investors
69
out of 100
Business Quality
Margins, moat, returns
85/100
Financial Strength
Debt, cash, stability
88/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
82/100
Why this score▼
Stable or improving margins · 95.1%Positive free cash flow · 0.41Consistent free cash flow · 4/5Reasonable earnings multiple · 7.74Manageable debt level · 0.1Healthy liquidity · 1.37
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Mandinach Jason William
Transaction: 01/22/2026
OTHER
Change
0
Price
Not reported
Filing
01/30/2026
Type
OTHER
Michel Mark D.
Transaction: 09/18/2025
OTHER
Change
0
Price
Not reported
Filing
09/25/2025
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Chang Stephen Koon Bong | OTHER | 0 | Not reported | 01/22/2026 | 02/02/2026 |
| Mandinach Jason William | OTHER | 0 | Not reported | 01/22/2026 | 01/30/2026 |
| Michel Mark D. | OTHER | 0 | Not reported | 09/18/2025 | 09/25/2025 |
| Morris Sonya | OTHER | 0 | Not reported | 09/18/2025 | 09/25/2025 |
| Bui Sonia E | OTHER | 0 | Not reported | 03/26/2025 | 04/03/2025 |
| Kraus Kristofer | OTHER | 0 | Not reported | 01/23/2025 | 01/31/2025 |
| Ferguson Benjamin | OTHER | 0 | Not reported | 01/23/2025 | 01/31/2025 |
| FLATTUM DAVID C | OTHER | 0 | Not reported | 12/01/2024 | 12/10/2024 |
| Ellis Michele Noel | OTHER | 0 | Not reported | 08/15/2024 | 08/21/2024 |
| Dinan Jaime Catherine | OTHER | 0 | Not reported | 08/15/2024 | 08/21/2024 |
| Bekkers Timothy Albert-Michel-Alain | OTHER | 0 | Not reported | 08/15/2024 | 08/21/2024 |
| UBS Group AG | SELL | -1,637 | Not reported | 04/17/2024 | 04/18/2024 |
| SHARENOW GREG ELLIOT | OTHER | 0 | Not reported | 01/25/2024 | 02/05/2024 |
| Kersman Alejandro Eduardo | OTHER | 0 | Not reported | 01/25/2024 | 02/05/2024 |
| Yang Jing | OTHER | 0 | Not reported | 01/25/2024 | 02/05/2024 |
| Chan Carol Kar-lon | OTHER | 0 | Not reported | 01/08/2024 | 01/17/2024 |
| Creighton Alyssa Michele | OTHER | 0 | Not reported | 01/08/2024 | 01/17/2024 |
| Goodman Matthew Louis | OTHER | 0 | Not reported | 01/08/2024 | 01/17/2024 |
| McLaughlin Colleen Patrice | OTHER | 0 | Not reported | 01/08/2024 | 01/17/2024 |
| Narain Shivanand | OTHER | 0 | Not reported | 01/08/2024 | 01/17/2024 |